Toxoplasmosis in Cats: Zoonotic Transmission and Public Health Concerns
Etiology
Toxoplasmosis is caused by the obligate intracellular apicomplexan parasite Toxoplasma gondii. This protozoan parasite has a complex life cycle that involves felids as the definitive host and a wide range of warm-blooded animals, including humans, as intermediate hosts [1, 2]. The parasite exists in three principal infectious stages: tachyzoites (rapidly dividing forms), bradyzoites (slowly dividing forms contained within tissue cysts), and sporozoites (contained within sporulated oocysts) [3, 4]. The tachyzoite stage is responsible for acute infection and dissemination, while bradyzoites establish chronic infection in tissues such as skeletal muscle, cardiac muscle, and neural tissue [5, 6]. The oocyst stage, which is shed exclusively in the feces of felids, is the environmentally resistant form that facilitates transmission to intermediate hosts [7, 8].
Life Cycle and Definitive Host Biology
The sexual phase of the T. gondii life cycle occurs exclusively within the intestinal epithelium of felids, making cats the only definitive host [9, 10]. A single-cell atlas of T. gondii sexual development in the feline intestinal tract has elucidated the transcriptional programs governing the transition from asexual to sexual stages [11]. After ingestion of tissue cysts (bradyzoites) from infected prey, the bradyzoites are released in the feline small intestine and invade enterocytes, where they undergo multiple rounds of asexual replication (schizogony) followed by gametogony and oocyst formation [10, 11]. The pre-sexual stages exhibit a distinct mode of cell division characterized by endodyogeny, a process in which two daughter cells are formed within the mother cell [10]. The dynamic landscape of microRNA expression in the feline small intestine during T. gondii infection has been characterized, revealing host microRNA responses that may modulate parasite replication and immune evasion [12].
Unsporulated oocysts are shed in the feces, a process that typically begins 3 to 10 days after primary infection and can last for 1 to 3 weeks [13, 14]. A single infected cat can shed millions of oocysts per day [14]. After shedding, oocysts require 1 to 5 days of exposure to oxygen and appropriate temperature and humidity to sporulate and become infectious [7, 8]. Sporulated oocysts are highly resistant to environmental degradation and can remain viable in soil, water, and on surfaces for months to years [1, 15].
Epidemiology and Seroprevalence
Seroprevalence of T. gondii in domestic cat populations varies widely by geographic region, management practices, and lifestyle. A study in Hong Kong reported seroprevalence rates of 27.3% in privately-owned cats and 37.8% in community cats, with demographic factors such as age and outdoor access significantly associated with seropositivity [13]. In Jordan, seroprevalence in cats was found to be 41.2% using serological methods, with molecular detection of T. gondii DNA in fecal samples confirming active shedding in a subset of animals [16]. A study in Bangkok, Thailand, detected T. gondii DNA in 8.3% of fecal samples from stray cats, indicating ongoing environmental contamination [14]. Seroprevalence in veterinary medicine professionals and students in Mexico was reported at 18.5%, highlighting occupational exposure risks [6].
The parasite also infects a broad range of intermediate hosts, including livestock and wildlife. Seroprevalence in goats from Nigeria was reported at 34.7%, with risk factors including age, breed, and management system [15]. In dairy cattle in Turkey, seroprevalence was 12.4% [17]. In pigs from eastern Spain, seroprevalence was low at 2.1% in intensive farms with controlled animal entry [18]. In deer from Iraq, seroprevalence was 15.6% [19]. In dogs from the Pantanal region of Brazil, seroprevalence was 54.2% for T. gondii [20]. These data underscore the widespread distribution of T. gondii in animal populations and the potential for zoonotic transmission.
Clinical Signs in Cats
Most immunocompetent cats infected with T. gondii remain asymptomatic [21, 16]. Clinical disease, when it occurs, is most commonly observed in kittens, immunocompromised adults, or cats with concurrent infections [22]. The clinical presentation depends on the organ systems affected. Ocular toxoplasmosis can present as uveitis, chorioretinitis, or anterior chamber inflammation [23]. Neurological signs, including ataxia, seizures, circling, and behavioral changes, are associated with cat toxoplasmosis brain involvement, where tachyzoites cause focal or multifocal necrotizing encephalitis [24, 25]. A study of 72 cats with pyogranulomatous and neutrophilic lymphadenitis identified toxoplasmosis as a differential diagnosis in a subset of cases [22]. Respiratory signs, including dyspnea and cough, can result from pneumonitis. Hepatic and pancreatic involvement may lead to icterus and vomiting. Myocarditis can cause arrhythmias and congestive heart failure.
Pathology
The pathological hallmark of acute toxoplasmosis is multifocal necrosis with a mixed inflammatory infiltrate composed of neutrophils, macrophages, and lymphocytes [26, 22]. In the brain, lesions consist of necrotic foci with microglial nodules, perivascular cuffing, and the presence of free tachyzoites or tissue cysts [24, 25]. In the lungs, interstitial pneumonia with alveolar edema and fibrin exudation is observed. In the liver, multifocal necrotizing hepatitis is common. Tissue cysts containing bradyzoites are found in skeletal muscle, cardiac muscle, and the central nervous system, and these cysts can persist for the life of the host without eliciting significant inflammation [5, 6].
Diagnostics
Diagnosis of feline toxoplasmosis relies on a combination of serological, molecular, and histopathological methods.
Serological Testing
Serological detection of anti-T. gondii antibodies is the most common diagnostic approach. The indirect fluorescent antibody test (IFAT) and enzyme-linked immunosorbent assays (ELISA) are widely used to detect IgM and IgG antibodies [2, 9]. A double-antigen sandwich colloidal gold immunochromatographic strip has been developed and validated for detection of T. gondii antibodies in multiple host species, including cats, offering a rapid point-of-care option [2]. A SAG1-based colloidal gold immunochromatographic strip has also been developed for serological detection in swine, with potential cross-species applicability [9]. The MIC17A antigen has been evaluated as a marker for both entero-epithelial and chronic stage infection in feline toxoplasmosis [21]. The AB blood group system phenotype does not play a role in T. gondii infection in cats [27].
Molecular Detection
Polymerase chain reaction (PCR) assays targeting the B1 gene or the 529 bp repeat element are highly sensitive and specific for detection of T. gondii DNA in blood, aqueous humor, cerebrospinal fluid, and tissue samples [14, 16, 28]. An antisense PCR assay has been developed and evaluated for detection of T. gondii in domestic cats, demonstrating improved sensitivity compared to conventional PCR [28]. PCR detection of T. gondii DNA in fecal samples is used to identify actively shedding cats, although the sensitivity is limited by intermittent shedding and the presence of PCR inhibitors in feces [14].
Histopathology and Cytology
Histopathological examination of biopsy or necropsy tissues can reveal characteristic lesions and the presence of tachyzoites or tissue cysts [26, 22]. Immunohistochemistry using anti-T. gondii antibodies can confirm the presence of the parasite in tissue sections. Cytological examination of cerebrospinal fluid, bronchoalveolar lavage fluid, or fine-needle aspirates may reveal tachyzoites in acute cases.
Diagnostic Workflow
graph TD
A[Clinical Suspicion of Feline Toxoplasmosis], > B{Serological Testing}
B, > C[IgM and IgG ELISA/IFAT]
C, > D{IgM Positive, IgG Negative or Low}
D, > E[Acute or Recent Infection]
C, > F{IgG Positive, IgM Negative}
F, > G[Chronic or Past Infection]
C, > H{Both IgM and IgG Positive}
H, > I[Active or Reactivated Infection]
B, > J[PCR on Blood, CSF, or Aqueous Humor]
J, > K{Positive}
K, > L[Confirm Active Infection]
J, > M{Negative}
M, > N[Does Not Rule Out Infection]
B, > O[Fecal PCR or Microscopy]
O, > P{Positive}
P, > Q[Active Oocyst Shedding]
O, > R{Negative}
R, > S[Does Not Rule Out Shedding]
B, > T[Histopathology with IHC]
T, > U[Definitive Diagnosis on Tissue]
Treatment
Treatment is indicated for cats with clinical signs of toxoplasmosis. The standard therapeutic regimen consists of clindamycin administered at 10 to 12 mg/kg orally every 12 hours for 2 to 4 weeks [22]. Alternative therapies include trimethoprim-sulfonamide combinations or pyrimethamine combined with a sulfonamide. Supportive care, including fluid therapy, nutritional support, and anti-inflammatory doses of corticosteroids for ocular or neurological inflammation, may be necessary. Treatment does not eliminate tissue cysts, and cats remain chronically infected [3, 8].
Control and Prevention
Control of toxoplasmosis in cats focuses on reducing exposure to the parasite and preventing environmental contamination. Cats should be kept indoors to prevent hunting of infected prey [13, 16]. Feeding only commercially processed or cooked food eliminates the risk of ingesting tissue cysts [15, 18]. Litter boxes should be cleaned daily, as oocysts require 1 to 5 days to sporulate and become infectious [7, 8]. Pregnant women and immunocompromised individuals should avoid handling cat litter or should wear disposable gloves and wash hands thoroughly after cleaning [29, 30].
Zoonotic Transmission and Public Health Concerns
Zoonotic transmission of T. gondii occurs primarily through ingestion of sporulated oocysts from contaminated environments or ingestion of tissue cysts in undercooked meat [1, 15, 31]. Toxoplasmosis in cat poop represents a major public health concern, as oocysts shed by cats can contaminate soil, water, and food sources [14, 16]. Oocysts can be transported via runoff into water supplies and can persist in the environment for extended periods [1, 15].
Human infection can also occur through congenital transmission from an infected mother to the fetus, which can result in miscarriage, stillbirth, or congenital toxoplasmosis with neurological and ocular sequelae [5, 7, 29]. A study in Turkey found anti-T. gondii antibody seropositivity in 38.5% of women with a history of abortion or stillbirth [5]. In Côte d'Ivoire, knowledge and practices towards toxoplasmosis among pregnant women were found to be inadequate, highlighting the need for public health education [7].
The parasite has been associated with a range of human health outcomes beyond congenital infection. Cerebral toxoplasmosis is a serious complication in immunocompromised individuals, such as organ transplant recipients [24]. Ocular toxoplasmosis can cause vision impairment and is a leading cause of posterior uveitis worldwide [23]. The association between T. gondii seropositivity and neuropsychiatric conditions, including psychotic experiences and changes in grey matter volume, has been investigated in population-based cohort studies [25]. The parasite's ability to alter host behavior has been documented in both animal models and human studies [32].
Seroprevalence in human populations varies widely. In sickle cell disease patients, seroprevalence was 45.5%, with blood transfusion history identified as a risk factor [31]. In quilombola communities in Brazil, seroprevalence was 68.2%, with risk factors including age, contact with soil, and consumption of raw meat [30]. Social marginalisation and environmental degradation have been linked to increased T. gondii exposure in urban informal settlements in Brazil [1].
Vaccine Development
Significant research efforts are directed towards developing vaccines against T. gondii for both veterinary and human use. Gene-edited live-attenuated vaccines have shown promise in preclinical studies, with targeted deletion of virulence genes resulting in strains that induce protective immunity without causing disease [3]. Advances in antigen discovery and mRNA vaccine platforms are being explored under a One Health framework [8]. The MIC17A antigen has been identified as a potential vaccine candidate due to its expression in both entero-epithelial and chronic stages [21].
References
[1] Eyre MT, Wang JY, Carneiro IO, et al. Social marginalisation, environmental degradation and Toxoplasma gondii exposure in urban informal settlements in Brazil. PLoS Negl Trop Dis. 2026. URL: https://pubmed.ncbi.nlm.nih.gov/42330015/
[2] Mu X, Chen C, Pu X, et al. Development and Field Validation of a Double-Antigen Sandwich Colloidal Gold Immunochromatographic Strip for Detection of Toxoplasma gondii Antibodies in Multiple Host Species. Transbound Emerg Dis. 2026. URL: https://pubmed.ncbi.nlm.nih.gov/42253330/
[3] Sang X, Zhang H, Zhang Y, et al. Gene-edited live-attenuated vaccines against Toxoplasma gondii: recent advances and future frontiers. Parasit Vectors. 2026. URL: https://pubmed.ncbi.nlm.nih.gov/42252477/
[4] Pinto GOA, Silva RAD, Oliveira PRF, et al. Molecular detection of Toxoplasma gondii in an aborted equine fetus and serological evidence of infection in mares enrolled in embryo transfer programs in Brazil. J Equine Vet Sci. 2026. URL: https://pubmed.ncbi.nlm.nih.gov/42252005/
[5] Karacali B, Mor N. Investigation of anti-Toxoplasma gondii antibody seropositivity and possible risk factors in women with abortion or stillbirth history in Kars, Turkey. Afr J Reprod Health. 2026. URL: https://pubmed.ncbi.nlm.nih.gov/42202767/
[6] de Velasco-Reyes I, Torres-García SE, Hernández-Rangel JJ, et al. Seroprevalence of Toxoplasma gondii Infection in Veterinary Medicine Professionals and Students in Aguascalientes, Mexico. Epidemiologia (Basel). 2026. URL: https://pubmed.ncbi.nlm.nih.gov/42201205/
[7] Henriette BA, Jémima EK, Jean-Sébastien MA, et al. First report of knowledge and practices towards toxoplasmosis among pregnant women in primary care in Abidjan, Côte d'Ivoire. Trop Parasitol. 2026. URL: https://pubmed.ncbi.nlm.nih.gov/42199683/
[8] Qadeer A, Tharwat M, Khan MZ, et al. Advances and Translational Challenges in Toxoplasma gondii Vaccine Development: From Antigen Discovery to mRNA and One Health Strategies. Vet Sci. 2026. URL: https://pubmed.ncbi.nlm.nih.gov/42188907/
[9] Chen XX, Sun H, Liang Y, et al. Development of a SAG1-based colloidal gold immunochromatographic strip for rapid serological detection of swine Toxoplasma gondii. Parasit Vectors. 2026. URL: https://pubmed.ncbi.nlm.nih.gov/42169035/
[10] Sena F, Hakimi M-A, Francia ME. Proliferating toward sex: characterization of cell division of Toxoplasma gondii's pre-sexual stages. mBio. 2026. URL: https://pubmed.ncbi.nlm.nih.gov/42153709/
[11] Alrubaye HS, Reilly SM, da Silva R, et al. A single-cell atlas of Toxoplasma sexual development in the feline intestinal tract. Nat Microbiol. 2026. URL: https://pubmed.ncbi.nlm.nih.gov/42020723/
[12] Zhai B, Bao B, Xie SC, et al. Dynamic landscape of microRNA expression in the feline small intestine during Toxoplasma gondii infection. Parasit Vectors. 2026. URL: https://pubmed.ncbi.nlm.nih.gov/41965856/
[13] Elsohaby I, Zubair M, Baqar Z, et al. Seroprevalence of Toxoplasma gondii and associated demographic factors in privately-owned dogs, cats, and community cats in Hong Kong. BMC Vet Res. 2026. URL: https://pubmed.ncbi.nlm.nih.gov/42135800/
[14] Kengradomkij C, Chimnoi W, Kamyingkird K, et al. PCR detection of Toxoplasma gondii DNA in fecal samples from stray cats in Bangkok Metropolitan, Thailand. Food Waterborne Parasitol. 2026. URL: https://pubmed.ncbi.nlm.nih.gov/42094705/
[15] Muhammad AS, Kudi AC, Mohammed A, et al. Public health significance of prevalence and risk factors associated with Toxoplasma gondii infection in goats sampled from two quarantine facilities and an institutional farm in Maiduguri metropolis, Borno state, Nigeria. Sci Rep. 2026. URL: https://pubmed.ncbi.nlm.nih.gov/42020619/
[16] Alkhatatbeh SK, Lafi SQ, Hammad HB, et al. The first seroprevalence and molecular detection of toxoplasmosis infecting cats in Jordan with associated risk factors. Vet Parasitol Reg Stud Reports. 2026. URL: https://pubmed.ncbi.nlm.nih.gov/41741047/
[17] Hanedan B, Taş BZ, Yıldırım E, et al. Investigation of Toxoplasma gondii seroprevalence and associated risk factors in dairy cattle in the Eastern Anatolia region of Türkiye. Vet Parasitol Reg Stud Reports. 2026. URL: https://pubmed.ncbi.nlm.nih.gov/41819961/
[18] Marín-García PJ, Ballesteros-García O, Martínez-Sáez L, et al. Low seroprevalence of Toxoplasma gondii in pig farms (Sus scrofa domesticus) of eastern Spain in intensive farms with control of animal entry. Vet Parasitol Reg Stud Reports. 2026. URL: https://pubmed.ncbi.nlm.nih.gov/41741032/
[19] Aziz KJ, Mikaeelb FB, Nasrullah OJ, et al. Seroepidemiological investigation of Toxoplasma gondi and Neospora caninum in local Deers in Erbil, Iraq. Vet Parasitol Reg Stud Reports. 2026. URL: https://pubmed.ncbi.nlm.nih.gov/42034957/
[20] Artiaga-Silva GL, de Lima Ruy Dias ÁF, Carvalho MR, et al. High Seroprevalence Rates of Toxoplasma gondii and Neospora caninum in Dogs in the Pantanal Region of Mato Grosso, Brazil. Acta Parasitol. 2026. URL: https://pubmed.ncbi.nlm.nih.gov/41843222/
[21] Günay-Esiyok Ö, Koçkaya ES, Yılmaz R, et al. The Potential of MIC17A both as an Entero-epithelial and Chronic Stage Marker for Detection of Feline Toxoplasmosis. Curr Microbiol. 2026. URL: https://pubmed.ncbi.nlm.nih.gov/41874672/
[22] Doyle E, Walker J. Diagnosis of pyogranulomatous and neutrophilic lymphadenitis in 72 cats presenting to a referral hospital: with a focus on nine cats with steroid-responsive lymphadenitis. J Feline Med Surg. 2026. URL: https://pubmed.ncbi.nlm.nih.gov/41527158/
[23] Askaryanzardak A, Kakkassery V, Tartaglione Gracia GP, et al. [Ocular toxoplasmosis in adults : Refresher course]. Ophthalmologie. 2026. URL: https://pubmed.ncbi.nlm.nih.gov/41603939/
[24] Mihaljević D, Sitaš Z, Hanulak J, et al. Cerebral Toxoplasmosis in a Renal Transplant Recipient-A Rare Complication. Life (Basel). 2026. URL: https://pubmed.ncbi.nlm.nih.gov/41900989/
[25] Jesuthasan J, Merritt K, Solmi F, et al. The association between childhood Toxoplasma gondii, psychotic experiences and grey matter volume: A population-based cohort study. Schizophr Res. 2026. URL: https://pubmed.ncbi.nlm.nih.gov/41643571/
[26] Ait Issad N, Mohamed Cherif A, Mebkhout F, et al. First report of molecular and histopathological detection of Toxoplasma gondii in aborted fetal goat myocardium in Algeria with associated risk factors. Parasitol Int. 2026. URL: https://pubmed.ncbi.nlm.nih.gov/41864556/
[27] Spada E, Tattarletti G, Proverbio D, et al. The AB Blood Group System Phenotype Does Not Play a Role in Toxoplasma gondii Infection in Cats. Pathogens. 2025. URL: https://pubmed.ncbi.nlm.nih.gov/41471183/ *** Disclaimer: This article is for educational and informational purposes only. It is not intended to substitute for professional veterinary advice, diagnosis, treatment, or regulatory guidance. Always consult a licensed veterinarian or qualified specialist regarding animal health, disease diagnosis, and therapeutic decisions.
[28] Li YY, Bai SY, Yu HQ, et al. Development and evaluation of an antisense PCR assay for Toxoplasma gondii detection in domestic cats. Vet Parasitol. 2026. URL: https://pubmed.ncbi.nlm.nih.gov/41724116/
[29] Gharbi M, Yera H, Dupouy-Camet J. [The cat, the women and the toxoplasma: What advice should be given to a pregnant woman who is seronegative for toxoplasmosis and owns a cat?]. Gynecol Obstet Fertil Senol. 2026. URL: https://pubmed.ncbi.nlm.nih.gov/41628830/
[30] Filho SCC, Moron SE, Ferreira RG, et al. Risk Factors and Ocular Health Associated with Toxoplasmosis in Quilombola Communities. Microorganisms. 2026. URL: https://pubmed.ncbi.nlm.nih.gov/41597614/
[31] Orish VN, Tetteh RE, Adzah D, et al. Toxoplasma gondii seropositivity among patients with sickle cell disease: Prevalence and association with blood transfusion history. PLoS One. 2026. URL: https://pubmed.ncbi.nlm.nih.gov/41931585/
[32] Loeb J. Thrill seekers: how parasites change host behaviour. Vet Rec. 2026. URL: https://pubmed.ncbi.nlm.nih.gov/41481062/
[33] Chalabi KN, Jabar Bakr E. Toxoplasmosis - knowledge among university students in Erbil, Iraq: a cross-sectional study. Int J Environ Health Res. 2026. URL: https://pubmed.ncbi.nlm.nih.gov/41873025/
[34] Murata FHA, Barboza JP, de Souza CAG, et al. Investigation of Toxoplasma gondii in reproductive tissues of companion animals from a municipal neutering program. Vet Parasitol Reg Stud Reports. 2026. URL: https://pubmed.ncbi.nlm.nih.gov/41651631/
[35] Biswas PK, Aryal D, Tarak AN, et al. Genotype distribution and risk factors of Toxoplasma gondii infection in animals of Trishal, Bangladesh. PLoS One. 2026. URL: https://pubmed.ncbi.nlm.nih.gov/41528989/